Condition
Parathyroid Gland
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed2
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06939946Phase 1Terminated
Intraoperative Parathyroid Gland (PTG) Identification Using a Hand-Held Imager (HHI)
NCT07010380Recruiting
Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)
NCT05113628Not ApplicableCompleted
Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
NCT04662437Completed
The Status of Parathyroid Hormone Secretion in Covid-19 Patients
Showing all 4 trials